GlobeNewswire by notified

ASM SET TO INVEST AROUND $100M IN KOREAN R&D, MANUFACTURING OPERATION, SIGNS MoU WITH TRADE, ENERGY & INDUSTRY MINISTRY

Share

Almere, The Netherlands Seoul, South Korea

February 2, 2023, 3:00 a.m. CET

ASM intends to significantly expand its manufacturing and innovation center in Dongtan, South Korea, through a multi-year investment totaling around US$100 million by 2025.

ASM International N.V. (Euronext Amsterdam: ASM) today announced its intention to invest around US$100 million in its manufacturing and innovation center in Dongtan, South Korea, by 2025, following the signing of a Memorandum of Understanding between ASM and the Ministry of Trade, Industry and Energy of the Republic of Korea (‘MOTIE’).

This investment will expand ASM’s R&D and product-development infrastructure to meet the needs of technology advances, as well as adding more manufacturing capacity. Korea is a key site for ASM, where some of its most advanced applications are developed – ASM’s ALD gap-fill applications are a recent and successful example. These applications enable next-generation advanced logic and memory devices, which are expected to see increased usage in coming years.

“Rapid growth is expected until the end of the decade for semiconductors, and – despite the recent slowing down in the industry – ASM continues to invest for growth,” says Benjamin Loh, CEO of ASM. “This expansion will not only serve our key Korean customers, but all our customers worldwide will benefit from the enabling technologies we develop in Korea.”

Lee Chang-yang, Korea's Minister of Trade, Industry and Energy, says: “The intended investment by ASM is expected to contribute greatly to increasing high-tech development in our country, securing a stable semiconductor supply chain, and increasing exports.”

Prior to signing the MoU, Minister Lee said that with semiconductor devices getting smaller and smaller, the increased investment in Korea by ASM – with its world-leading ALD technology – would present good cause for the country to ‘exert synergy’ with domestic semiconductor companies. Minister Lee also expressed his willingness to cooperate closely with ASM as part of the Korean government’s policy to foster and support the semiconductor industry.

Dongtan has been instrumental in ASM’s growth, with the facility delivering advanced R&D and technology for customers in Korea and for global customers. Korea is also the global center for ASM’s PEALD business. Technologies developed by ASM’s local R&D team have been at the heart of breakthrough innovations in the semiconductor industry, such as the ALD quad chamber module (QCM) architecture, the TENZATM ALD for ultra-high aspect ratio (>100:1) gap-fill, and high-quality PEALD oxides and nitrides for spacers, liners, and other patterning applications.

The expansion of ASM’s Dongtan facility is also required to create more space for the company’s fast-growing number of employees in Korea, and reflects the increasing revenue contribution from the Korean market expected over the next few years.

The intended investment will deliver multiple benefits to the local market. Of course, the expansion will create new job opportunities, for the direct and indirect employment of skilled personnel in engineering, R&D and manufacturing. In addition to contributing to training and workforce development in Korea, the investment will also benefit local supplier partnerships.

ASM has been operating in Korea since 1989 and established ASM Korea Limited in 1995. Since then, Korea has grown into one of ASM’s key global technology development and manufacturing sites with more than 450 employees.

The MoU has been signed but is conditional on support and assistance from the Korean government, in terms of grants and the speedy approval of all necessary permits.

This intended expansion follows the unveiling last year of ASM’s state-of-the-art Singapore manufacturing facility and operations hub, another step in the company’s growth as it prepares to meet growing global customer demand for advanced semiconductors.

About ASM International

ASM International N.V., headquartered in Almere, the Netherlands, and its subsidiaries design and manufacture equipment and process solutions to produce semiconductor devices for wafer processing, and have facilities in the United States, Europe, and Asia. ASM International's common stock trades on the Euronext Amsterdam Stock Exchange (symbol ASM). For more information, visit ASM's website at www.asm.com

Cautionary Note Regarding Forward-Looking Statements: All matters discussed in this press release, except for any historical data, are forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These include, but are not limited to, economic conditions and trends in the semiconductor industry generally and the timing of the industry cycles specifically, currency fluctuations, corporate transactions, financing and liquidity matters, the success of restructurings, the timing of significant orders, market acceptance of new products, competitive factors, litigation involving intellectual property, shareholders or other issues, commercial and economic disruption due to natural disasters, terrorist activity, armed conflict or political instability, changes in import/export regulations, epidemics and other risks indicated in the Company's reports and financial statements. The Company assumes no obligation nor intends to update or revise any forward-looking statements to reflect future developments or circumstances.

This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

CONTACT

Investor and media contact:
Victor Bareño
T: +31 88 100 8500
E: investor.relations@asm.com

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Årsrapport for 2022 - Selskabsmeddelelse nr. 1/202327.3.2023 23:07:48 CEST | pressemeddelelse

ÅRSRAPPORT FOR 2022 UDBYTTESTRØM OG LIKVIDITET BEDRE END FORVENTET, TIL TRODS FOR SVÆRE MARKEDER PÅVIRKET AF COVID Hovedpunkter for 2022 - Koncernen Resultat for året blev et tab på DKK 1,5 mio. (DKK -0,5 mio.).Totale pengestrømme for året på DKK -9,1 mio. (2021: positive pengestrømme på DKK 0,8 mio.)Likvide midler pr. 31. december 2022 på DKK 13,0 (DKK 21,9 mio.), heraf DKK 3,5 mio. i moderselskabet EAC Invest, DKK 5,8 mio. i Thailand og DKK 3,7 mio. indestår i Kina og er ikke til umiddelbar disposition for EAC Invest koncernen udenfor Kina.Udbytter fra investeringer udgjorde DKK 3,4 mio., og var lidt højere end oprindeligt forventet.Thai Poly Acrylic var i 2022 hårdt ramt af efterdønninger fra Covid-19 og stigende priser på råmaterialer, hvilket påvirkede salget og resultatet var betydeligt under forventning.Udbyttebetaling på DKK 1.000 pr. aktie og i alt DKK 10 mio. blev gennemført i april 2022. Forventninger for 2023 - Koncernen Forventede driftsomkostninger (primært driftsresultat

Nyxoah Raises $3 Million from an At-the-Market Equity Offering27.3.2023 22:05:00 CEST | Press release

INSIDE INFORMATION REGULATED INFORMATION Nyxoah Raises $3 Million from an At-the-Market Equity Offering Mont-Saint-Guibert, Belgium – March 27, 2023, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company raised $2.8 million in gross proceeds pursuant to the Company’s $50 million at-the-market ("ATM") program established on December 22, 2022 at an issue price equal to the market price on the Nasdaq Global Market at the time of the sale. The shares were purchased by historical Nyxoah shareholder Cochlear Limited, and the proceeds will be used for general corporate purposes. The ordinary shares described above were sold pursuant to the Company’s shelf registration statement on Form F-3 (File No. 333-268955), previously filed with the Securities and Exchange Commission (“SEC

Convocation of the 2023 Annual General Meeting of Shareholders and Proposed Resolutions27.3.2023 20:30:00 CEST | Press release

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014). EINDHOVEN, Pays-Bas et LAUSANNE, Suisse, et BOSTON, MA, Etats-Unis, March 27, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD) (the Company), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today has convened the 2023 Annual General Meeting of Shareholders (AGM), including the resolutions to be submitted for adoption at the AGM, which will be held in Amsterdam, the Netherlands, on May 8, 2023. The resolutions, proposed by the Board, to be submitted for adoption at the AGM, are as follows: Adoption of the Company’s statutory annual accounts for the financial year ended December 31, 2022, prepared in accordance with International Financial Reporting Standards (IFRS-EU). The 2022 statutory accounts were filed with the Netherlands Authority for the Fina

ONWARD Reports 2022 Full Year Financial and Operating Results27.3.2023 20:00:00 CEST | Press release

Company also Provides Business Update and Outlook for 2023 - Conference Call and Webcast (in English) March 28, 2023, at 2:00 PM CEST/8:00 AM EDT THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, LAUSANNE, Switzerland & BOSTON, MA USA, March 27, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces its 2022 financial and operating results. The full Annual Report is available here, on the Company’s website in the Investors section (https://ir.onwd.com), and on the website of the Netherlands Authority for the Financial Markets (www.afm.nl). “I am proud of the volume and significance of our team’s achievements as we prepare for commercialization of our first therapy in late 2023 or early 2024,” said Dave Marver, CEO

Nokia Corporation: Repurchase of own shares on 27.03.202327.3.2023 20:00:00 CEST | Press release

Nokia Corporation Stock Exchange Release 27 March 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 27.03.2023 Espoo, Finland – On 27 March 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL284,4184.39CEUX14,3074.40AQEU2904.39TQEX9854.38Total300,0004.39 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023 and en